Watch this recorded webinar to hear about strategies and opportunities to collaborate and partner with Daiichi Sankyo Co., Ltd, one of Japan’s leading research based pharmaceutical companies.
In this webinar, Mr. Yuichi Kubo, Vice President, Business Development and Licensing will explain about the overview of Daiichi Sankyo’s business and partnering strategy and areas of potential collaboration opportunities.
The Speaker
UK Trade & Investment Japan’s Head of Trade, Richard Buttrey will host our special guest speaker.
Mr. Yuichi Kubo, Vice President, Business Development and Licensing, Daiichi Sankyo Co., Ltd.
Mr. Yuichi Kubo started his business career at Daiichi Pharmaceutical Co., Ltd. in 1980. He was based in London from 1990-1996 as a project manager for clinical development in Europe. At the integration of Daiichi and Sankyo, he was appointed as VP, Head of Development Research of US subsidiary, coordinating non-clinical and pharmaceutical development activities, followed by the role of Vice President for Translational Medicine and Clinical Pharmacology in Japan, and from 2012 Global Head of Intellectual Property. He is appointed to the current position as of April 2014. He was trained as a biochemist and holds a Master’s degree in pharmaceutical science.
Benefits of Watching
This webinar will explain:
· Japan’s major pharmaceutical company’s strategy for product development
· Areas of possible collaboration between Daiichi Sankyo Co., Ltd. and your company
Click here to download the report
The remainder of this article is a resource for members only. Please register or login to access.
Get free and unlimited access to in-depth market reports, videos, invitations to relevant events and priority support. Join here.
To find out your market potential in Japan, please Send Us Your Enquiry.
For additional content concerning this sector, you may find our Life Sciences page useful.
